Preclinical models for drug selection in myeloproliferative neoplasms. [electronic resource]
Producer: 20140512Description: 317-24 p. digitalISSN:- 1558-822X
- Animals
- Antineoplastic Agents -- therapeutic use
- Disease Models, Animal
- Drug Evaluation, Preclinical
- GATA1 Transcription Factor -- physiology
- Gene Knock-In Techniques
- Hematologic Neoplasms -- drug therapy
- Humans
- Janus Kinase 2 -- antagonists & inhibitors
- Mice
- Mice, Transgenic
- Molecular Targeted Therapy -- methods
- Myeloproliferative Disorders -- drug therapy
- Protein Kinase Inhibitors -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.